issue contents
April 2022 issue

Cover illustration: Ribbon diagram and surface representation of two perpendicular views of the D-alanyl carrier protein ligase DltA from Staphylococcus aureus Mu50 with an ATP molecule bound in the active site [Lee et al. (2022), Acta Cryst. D78, 424–434]. The D-alanylation pathway has emerged as a promising antibacterial target against drug-resistant S. aureus and DltA is the first protein in this pathway.
CCP-EM
access
accessresearch papers
access
access
access
access
access
access
access
journal menu







